நஜ்லா குத்ரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Farlong Pharmaceutical Announces Three-Year Clinical Trial Determining the Effect of Farlong NotoGinseng™ Published in Current Nutraceuticals Journal by Bentham Science
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Auf und davon : Wundermittel „Ketamin – diese Firma profitiert bereits mit eigenen Kliniken und einem Mega-Joker-Asset!
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
KGK Science CEO: Pandemic put transition to virtual trials into hyperdrive
nutraingredients-usa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nutraingredients-usa.com Daily Mail and Mail on Sunday newspapers.
The Vancouver-based investment company agreed to purchase KGK for up to $16.5 million.
Transaction Details: The sum Myconic has agreed to pay includes $12.5 million purchase price, $1.5 million payable if KGK achieves gross revenues of $8 million in any 12 months over the two years following the closing and $2.5 million credit against future KGK services to Auxly within the next 10 years.
The purchase price consists of $1.5 million in cash payable on closing, $1 million in cash payable six months following the closing, and $10 million in Myconic shares valued at $1.55 per share and issued on the closing date of the transaction.
The acquisition is scheduled to finalize on or around the week of June 7.